-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Artiva Biotherapeutics, Raises Price Target to $15

Benzinga·11/12/2025 18:53:21
Listen to the news
HC Wainwright & Co. analyst Emily Bodnar maintains Artiva Biotherapeutics (NASDAQ:ARTV) with a Buy and raises the price target from $12 to $15.